Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/12/2012US20120088775 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof
04/12/2012US20120088774 Active pharmaceutical ingredient adsorbed on solid support
04/12/2012US20120088773 Circadian rhythm modulation
04/12/2012US20120088772 Novel pharmaceutical composition for prevention and/or treatment of attention deficit/hyperactivity disorder
04/12/2012US20120088771 Tissue-nonspecific alkaline phosphatase (tnap): a therapeutic target for arterial calcification
04/12/2012US20120088770 Alpha helix mimetics and methods relating thereto
04/12/2012US20120088769 Salts of arylsulfonamide ccr3 antagonists
04/12/2012US20120088768 Pinane-substituted pyrimidinediamine derivatives useful as axl inhibitors
04/12/2012US20120088767 Benzimidazole derivatives as pi3 kinase inhibitors
04/12/2012US20120088766 Fused heterocyclic compounds and their uses
04/12/2012US20120088765 Purine derivative and antitumor agent using same
04/12/2012US20120088764 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
04/12/2012US20120088763 Triazolopyridine derivatives and their therapeutic use
04/12/2012US20120088762 Compounds for enzyme inhibition
04/12/2012US20120088761 Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders
04/12/2012US20120088760 Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient
04/12/2012US20120088759 Thiazolidin-4-one and [1,3]-thiazinan-4-one compounds as orexin receptor antagonists
04/12/2012US20120088758 Five-membered heterocycles useful as serine protease inhibitors
04/12/2012US20120088757 Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties
04/12/2012US20120088756 Methods for Regulating Neurotransmitter Systems by Inducing Counteradaptations
04/12/2012US20120088755 Novel Compounds
04/12/2012US20120088754 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
04/12/2012US20120088753 Pyrrolopyrimidines and used as kinase inhibitors
04/12/2012US20120088752 Hedgehog pathway antagonists and therapeutic applications thereof
04/12/2012US20120088751 Pharmaceutical compounds
04/12/2012US20120088750 Antibacterial compounds
04/12/2012US20120088749 S1P Receptor Modulating Compounds and Use Thereof
04/12/2012US20120088748 Heterocyclic compounds
04/12/2012US20120088747 Sulfonamide containing compounds and uses thereof
04/12/2012US20120088746 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
04/12/2012US20120088745 Chemically modified small molecules
04/12/2012US20120088744 Compositions for treating cmt and related disorders
04/12/2012US20120088743 Combinations comprising antimuscarinic agents and pde4 inhibitors
04/12/2012US20120088742 Acetylsalicylic acid salts
04/12/2012US20120088741 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
04/12/2012US20120088740 Co-crystals and pharmaceutical compositions comprising the same
04/12/2012US20120088739 Method for treating meibomian gland disease
04/12/2012US20120088738 Inhibitors of fatty acid amide hydrolase
04/12/2012US20120088737 Novel acyl guanidine derivatives
04/12/2012US20120088736 [4-(6-HALO-7-Substituted-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLIN-3-YL)-PHENYL]-5-CHLORO-THIOPHEN-2-YL-SULFONYLUREAS and Forms and Methods Related Thereto
04/12/2012US20120088735 One-Step Processing of Hydrogels for Mechanically Robust and Chemically Desired Features
04/12/2012US20120088731 Method for treating parkinson's disease through regulating vdac1 protein
04/12/2012US20120088730 Use of angiotensin converting enzyme (ace) domain specific inhibitors to inhibit or enhance cytokine production and alter immune response
04/12/2012US20120088727 Rspondins as modulators of angiogenesis and vasculogenesis
04/12/2012US20120088726 Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical fromulations
04/12/2012US20120088725 5-cnac as oral delivery agent for parathyroid hormone fragments
04/12/2012US20120088723 Selective ep4 receptor agonistic substance for treatment of cancer
04/12/2012US20120088721 Cartilage Repair
04/12/2012US20120088718 Hcv-derived polypeptides and uses thereof
04/12/2012US20120088671 Anti-biofilm compositions and methods for using
04/12/2012US20120088664 Antifungal 1,2,4-triazolyl derivatives having a 5-sulfur subtituent
04/12/2012US20120088663 Triazole Compounds Carrying a Sulfur Substituent
04/12/2012US20120088660 Antifungal 1,2,4-triazolyl Derivatives
04/12/2012US20120087997 Edible products with thermostatic and cognitive effects
04/12/2012US20120087994 Systemic administration of nac as an adjunct in the treatment of bioterror exposures such as smallpox and use in combination with dhea for the treatment of smallpox
04/12/2012US20120087992 miRNAS AS THERAPEUTIC TARGETS IN CANCER
04/12/2012US20120087991 Mucositis prevention supplement and treatment
04/12/2012US20120087986 Pharmaceutical formulations comprising desvenlafaxine
04/12/2012US20120087984 Stabilization of chemical compounds using nanoparticulate formulations
04/12/2012US20120087982 Extended release opioid abuse deterrent compositions and methods of making same
04/12/2012US20120087981 Skin Engaging Member Comprising Encapsulated Actives
04/12/2012US20120087980 Stimulation of neuroregeneration by flavonoid glycosides
04/12/2012US20120087979 Extended-release oral dosage forms for poorly soluble amine drugs
04/12/2012US20120087978 Dosage forms of apixaban
04/12/2012US20120087975 Method of Producing A Cationic Liposomal Preparation Comprising A Lipophilic Compound
04/12/2012US20120087974 Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages
04/12/2012US20120087973 siRNA MICROBICIDES FOR PREVENTING AND TREATING DISEASES
04/12/2012US20120087971 Contact drug delivery system
04/12/2012US20120087970 Apparatus and Method for Removing Epithelium from the Cornea
04/12/2012US20120087959 Nanodispersion of a drug and process for its preparation
04/12/2012US20120087957 Process for the preparation of pharmaceutical suspensions for inhalation
04/12/2012US20120087955 Nanoparticulate megestrol formulations
04/12/2012US20120087953 Pharmaceutical compositions of active pharmaceutical ingredient comprising sulphonylurea moiety with excellent dissolution properties
04/12/2012US20120087952 Pulmonary Delivery in Treating Disorders of the Central Nervous System
04/12/2012US20120087950 Functionalized calcium phosphate artificial bone and joint compositions and methods of use and manufacture
04/12/2012US20120087949 Oligonucleotide micelles
04/12/2012US20120087947 Use of 2,5-dihydroxybenzene derivatives for treating dermatitis
04/12/2012US20120087943 Agent for preventing adverse side effects of carcinostatic agent
04/12/2012US20120087940 Vector for treating alzheimer's disease
04/12/2012US20120087931 Therapeutic and diagnostic anti-hsp70 antibodies
04/12/2012US20120087928 Therapeutics for age-related macular degeneration
04/12/2012US20120087923 Antibodies to OPGL
04/12/2012US20120087918 Methods and compositions for inhibiting the growth of hematopoietic malignant cells
04/12/2012US20120087915 Use of inhibitors of bruton's tyrosine kinase (btk)
04/12/2012US20120087914 Inhibition of trim62 activity reduces cancer cell proliferation
04/12/2012US20120087913 Induction of tumor hypoxia for cancer therapy
04/12/2012US20120087904 Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Skin Cancer
04/12/2012US20120087899 Heparan Sulphate
04/12/2012US20120087893 Combinations of a hcv inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent
04/12/2012US20120087891 Reversible Gel-forming Compositions for Controlled Delivery of Bioactive Substances
04/12/2012US20120087887 Composition and Method for Arresting Blood Flow and for Forming a Persistent Microbial Barrier
04/12/2012US20120087876 Avermectin/metronidazole compositions for treating afflictions of the skin, e.g., rosacea
04/12/2012US20120087874 Warming compositions and delivery systems therefor
04/12/2012US20120087873 Urea Foam
04/12/2012US20120087869 Methods for distributing agents to areas of brain
04/12/2012US20120087859 Nanocarrier having enhanced skin permeability, cellular uptake and tumour delivery properties
04/12/2012DE102011100689A1 Screening living tissues of pituitary or pituitary hormone production system, comprises providing a mixture of extracts of e.g. Agni casti fructus in form of library, and contacting single-substance mixture with tissues of pituitary
04/12/2012DE102010047714A1 Derivate von Steroidbenzylaminen mit antiparasitärer, antibakterieller, antimykotischer und/oder antiviraler Wirkung Derivatives of Steroidbenzylaminen with antiparasitic, antibacterial, antifungal and / or antiviral action
04/12/2012DE102010042360A1 Nasal spray bottle, useful for dilution of drug to be administered, and for preventing or treating rhinitis medicamentosa, preferably withdrawal rhinitis medicamentosa, comprises a spray nozzle and a two chamber system
04/12/2012CA2822024A1 Use of hyaluronan for promoting angiogenesis
1 ... 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 ... 7860